SLC6A14, a Na+/Cl−-coupled amino acid transporter, functions as a tumor promoter in colon and is a target for Wnt signaling
出版年份 2020 全文链接
标题
SLC6A14, a Na+/Cl−-coupled amino acid transporter, functions as a tumor promoter in colon and is a target for Wnt signaling
作者
关键词
-
出版物
BIOCHEMICAL JOURNAL
Volume 477, Issue 8, Pages 1409-1425
出版商
Portland Press Ltd.
发表日期
2020-03-27
DOI
10.1042/bcj20200099
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- SLC1A5 glutamine transporter is a target of MYC and mediates reduced mTORC1 signaling and increased fatty acid oxidation in long‐lived Myc hypomorphic mice
- (2019) Xiaoai Zhao et al. AGING CELL
- MYC promotes tryptophan uptake and metabolism by the kynurenine pathway in colon cancer
- (2019) Niranjan Venkateswaran et al. GENES & DEVELOPMENT
- Lactate/GPR81 signaling and proton motive force in cancer: Role in angiogenesis, immune escape, nutrition, and Warburg phenomenon
- (2019) Timothy P. Brown et al. PHARMACOLOGY & THERAPEUTICS
- The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)
- (2018) Yann Cormerais et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CD133: beyond a cancer stem cell biomarker
- (2018) Amir Barzegar Behrooz et al. JOURNAL OF DRUG TARGETING
- The Human SLC7A5 (LAT1): The Intriguing Histidine/Large Neutral Amino Acid Transporter and Its Relevance to Human Health
- (2018) Mariafrancesca Scalise et al. Frontiers in Chemistry
- P–TNM staging system for colon cancer: combination of P-stage and AJCC TNM staging system for improving prognostic prediction and clinical management
- (2018) Qi Liu et al. Cancer Management and Research
- The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate
- (2017) Pranavi Koppula et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- Glutamine transporters in mammalian cells and their functions in physiology and cancer
- (2016) Yangzom D. Bhutia et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer
- (2016) V Coothankandaswamy et al. BRITISH JOURNAL OF PHARMACOLOGY
- Wnt signaling in cancer
- (2016) T Zhan et al. ONCOGENE
- Colorectal cancer carcinogenesis: a review of mechanisms
- (2016) Kanwal Tariq et al. Cancer Biology & Medicine
- Deletion of the amino acid transporter Slc6a14 suppresses tumour growth in spontaneous mouse models of breast cancer
- (2015) Ellappan Babu et al. BIOCHEMICAL JOURNAL
- Amino Acid Transporters in Cancer and Their Relevance to "Glutamine Addiction": Novel Targets for the Design of a New Class of Anticancer Drugs
- (2015) Y. D. Bhutia et al. CANCER RESEARCH
- Ferroptosis as a p53-mediated activity during tumour suppression
- (2015) Le Jiang et al. NATURE
- ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
- (2015) M van Geldermalsen et al. ONCOGENE
- The amino acid transporter SLC6A14 in cancer and its potential use in chemotherapy
- (2014) Yangzom D. Bhutia et al. Asian Journal of Pharmaceutical Sciences
- Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target
- (2013) Luika A. Timmerman et al. CANCER CELL
- The Cystine/Glutamate Antiporter System xc− in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities
- (2012) Jan Lewerenz et al. ANTIOXIDANTS & REDOX SIGNALING
- The plasma membrane transporter SLC5A8 suppresses tumour progression through depletion of survivin without involving its transport function
- (2012) Veena Coothankandaswamy et al. BIOCHEMICAL JOURNAL
- Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis
- (2012) M Christie et al. ONCOGENE
- CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc− and Thereby Promotes Tumor Growth
- (2011) Takatsugu Ishimoto et al. CANCER CELL
- Methylation of Cancer-Stem-Cell-Associated Wnt Target Genes Predicts Poor Prognosis in Colorectal Cancer Patients
- (2011) Felipe de Sousa E Melo et al. Cell Stem Cell
- SLC6A14 (ATB0,+) Protein, a Highly Concentrative and Broad Specific Amino Acid Transporter, Is a Novel and Effective Drug Target for Treatment of Estrogen Receptor-positive Breast Cancer
- (2011) Senthil Karunakaran et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Projections of the Cost of Cancer Care in the United States: 2010-2020
- (2011) A. B. Mariotto et al. JNCI-Journal of the National Cancer Institute
- CD133+ colon cancer cells are more interactive with the tumor microenvironment than CD133− cells
- (2011) Celia Chao et al. LABORATORY INVESTIGATION
- A ‘metastasis-prone’ signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics
- (2010) Yi Hong et al. CLINICAL & EXPERIMENTAL METASTASIS
- Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy
- (2009) Paul Nicklin et al. CELL
- Molecular Basis of Colorectal Cancer
- (2009) Sanford D. Markowitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy
- (2008) Senthil Karunakaran et al. BIOCHEMICAL JOURNAL
- Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond
- (2008) Vadivel Ganapathy et al. PHARMACOLOGY & THERAPEUTICS
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started